Global Clinical Trial Logistic 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI08246805

Publication Date:

August 22, 2024

Pages:

114

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Clinical Trial Logistic market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
The 鈥淐linical Trial Logistic Industry Forecast鈥� looks at past sales and reviews total world Clinical Trial Logistic sales in 2023, providing a comprehensive analysis by region and market sector of projected Clinical Trial Logistic sales for 2024 through 2030. With Clinical Trial Logistic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Trial Logistic industry.
This Insight Report provides a comprehensive analysis of the global Clinical Trial Logistic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Clinical Trial Logistic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Clinical Trial Logistic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Trial Logistic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Trial Logistic.
United States market for Clinical Trial Logistic is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Clinical Trial Logistic is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Clinical Trial Logistic is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Clinical Trial Logistic players cover Alamc Group, Catalent, PCI Services, Parexel International Corporation and Sharp Packaging Services, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Trial Logistic market by product type, application, key players and key regions and countries.
Segmentation by type
Prevention Trials
Screening Trials
Treatment Trials
Multi-arm Multi-stage (MAMS) Trials
Segmentation by application
Medical Device Industry
Biopharmaceuticals Industry
Pharmaceuticals Industry
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Alamc Group
Catalent
PCI Services
Parexel International Corporation
Sharp Packaging Services
Biocair
O&M Movianto
KLIFO A/S
Thermo Fisher Scientific
Capsugel
UDG Healthcare
DHL International GmbH
Bilcare Limited
PRA Health Sciences

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Clinical Trial Logistic 麻豆原创 Size 2019-2030
2.1.2 Clinical Trial Logistic 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Clinical Trial Logistic Segment by Type
2.2.1 Prevention Trials
2.2.2 Screening Trials
2.2.3 Treatment Trials
2.2.4 Multi-arm Multi-stage (MAMS) Trials
2.3 Clinical Trial Logistic 麻豆原创 Size by Type
2.3.1 Clinical Trial Logistic 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Clinical Trial Logistic 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Clinical Trial Logistic Segment by Application
2.4.1 Medical Device Industry
2.4.2 Biopharmaceuticals Industry
2.4.3 Pharmaceuticals Industry
2.4.4 Others
2.5 Clinical Trial Logistic 麻豆原创 Size by Application
2.5.1 Clinical Trial Logistic 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Clinical Trial Logistic 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Clinical Trial Logistic 麻豆原创 Size by Player
3.1 Clinical Trial Logistic 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Clinical Trial Logistic Revenue by Players (2019-2024)
3.1.2 Global Clinical Trial Logistic Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Clinical Trial Logistic Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Clinical Trial Logistic by Regions
4.1 Clinical Trial Logistic 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Clinical Trial Logistic 麻豆原创 Size Growth (2019-2024)
4.3 APAC Clinical Trial Logistic 麻豆原创 Size Growth (2019-2024)
4.4 Europe Clinical Trial Logistic 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Clinical Trial Logistic 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Clinical Trial Logistic 麻豆原创 Size by Country (2019-2024)
5.2 Americas Clinical Trial Logistic 麻豆原创 Size by Type (2019-2024)
5.3 Americas Clinical Trial Logistic 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Clinical Trial Logistic 麻豆原创 Size by Region (2019-2024)
6.2 APAC Clinical Trial Logistic 麻豆原创 Size by Type (2019-2024)
6.3 APAC Clinical Trial Logistic 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Clinical Trial Logistic by Country (2019-2024)
7.2 Europe Clinical Trial Logistic 麻豆原创 Size by Type (2019-2024)
7.3 Europe Clinical Trial Logistic 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Clinical Trial Logistic by Region (2019-2024)
8.2 Middle East & Africa Clinical Trial Logistic 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Clinical Trial Logistic 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Clinical Trial Logistic 麻豆原创 Forecast
10.1 Global Clinical Trial Logistic Forecast by Regions (2025-2030)
10.1.1 Global Clinical Trial Logistic Forecast by Regions (2025-2030)
10.1.2 Americas Clinical Trial Logistic Forecast
10.1.3 APAC Clinical Trial Logistic Forecast
10.1.4 Europe Clinical Trial Logistic Forecast
10.1.5 Middle East & Africa Clinical Trial Logistic Forecast
10.2 Americas Clinical Trial Logistic Forecast by Country (2025-2030)
10.2.1 United States Clinical Trial Logistic 麻豆原创 Forecast
10.2.2 Canada Clinical Trial Logistic 麻豆原创 Forecast
10.2.3 Mexico Clinical Trial Logistic 麻豆原创 Forecast
10.2.4 Brazil Clinical Trial Logistic 麻豆原创 Forecast
10.3 APAC Clinical Trial Logistic Forecast by Region (2025-2030)
10.3.1 China Clinical Trial Logistic 麻豆原创 Forecast
10.3.2 Japan Clinical Trial Logistic 麻豆原创 Forecast
10.3.3 Korea Clinical Trial Logistic 麻豆原创 Forecast
10.3.4 Southeast Asia Clinical Trial Logistic 麻豆原创 Forecast
10.3.5 India Clinical Trial Logistic 麻豆原创 Forecast
10.3.6 Australia Clinical Trial Logistic 麻豆原创 Forecast
10.4 Europe Clinical Trial Logistic Forecast by Country (2025-2030)
10.4.1 Germany Clinical Trial Logistic 麻豆原创 Forecast
10.4.2 France Clinical Trial Logistic 麻豆原创 Forecast
10.4.3 UK Clinical Trial Logistic 麻豆原创 Forecast
10.4.4 Italy Clinical Trial Logistic 麻豆原创 Forecast
10.4.5 Russia Clinical Trial Logistic 麻豆原创 Forecast
10.5 Middle East & Africa Clinical Trial Logistic Forecast by Region (2025-2030)
10.5.1 Egypt Clinical Trial Logistic 麻豆原创 Forecast
10.5.2 South Africa Clinical Trial Logistic 麻豆原创 Forecast
10.5.3 Israel Clinical Trial Logistic 麻豆原创 Forecast
10.5.4 Turkey Clinical Trial Logistic 麻豆原创 Forecast
10.5.5 GCC Countries Clinical Trial Logistic 麻豆原创 Forecast
10.6 Global Clinical Trial Logistic Forecast by Type (2025-2030)
10.7 Global Clinical Trial Logistic Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Alamc Group
11.1.1 Alamc Group Company Information
11.1.2 Alamc Group Clinical Trial Logistic Product Offered
11.1.3 Alamc Group Clinical Trial Logistic Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Alamc Group Main Business Overview
11.1.5 Alamc Group Latest Developments
11.2 Catalent
11.2.1 Catalent Company Information
11.2.2 Catalent Clinical Trial Logistic Product Offered
11.2.3 Catalent Clinical Trial Logistic Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Catalent Main Business Overview
11.2.5 Catalent Latest Developments
11.3 PCI Services
11.3.1 PCI Services Company Information
11.3.2 PCI Services Clinical Trial Logistic Product Offered
11.3.3 PCI Services Clinical Trial Logistic Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 PCI Services Main Business Overview
11.3.5 PCI Services Latest Developments
11.4 Parexel International Corporation
11.4.1 Parexel International Corporation Company Information
11.4.2 Parexel International Corporation Clinical Trial Logistic Product Offered
11.4.3 Parexel International Corporation Clinical Trial Logistic Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Parexel International Corporation Main Business Overview
11.4.5 Parexel International Corporation Latest Developments
11.5 Sharp Packaging Services
11.5.1 Sharp Packaging Services Company Information
11.5.2 Sharp Packaging Services Clinical Trial Logistic Product Offered
11.5.3 Sharp Packaging Services Clinical Trial Logistic Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Sharp Packaging Services Main Business Overview
11.5.5 Sharp Packaging Services Latest Developments
11.6 Biocair
11.6.1 Biocair Company Information
11.6.2 Biocair Clinical Trial Logistic Product Offered
11.6.3 Biocair Clinical Trial Logistic Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Biocair Main Business Overview
11.6.5 Biocair Latest Developments
11.7 O&M Movianto
11.7.1 O&M Movianto Company Information
11.7.2 O&M Movianto Clinical Trial Logistic Product Offered
11.7.3 O&M Movianto Clinical Trial Logistic Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 O&M Movianto Main Business Overview
11.7.5 O&M Movianto Latest Developments
11.8 KLIFO A/S
11.8.1 KLIFO A/S Company Information
11.8.2 KLIFO A/S Clinical Trial Logistic Product Offered
11.8.3 KLIFO A/S Clinical Trial Logistic Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 KLIFO A/S Main Business Overview
11.8.5 KLIFO A/S Latest Developments
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Information
11.9.2 Thermo Fisher Scientific Clinical Trial Logistic Product Offered
11.9.3 Thermo Fisher Scientific Clinical Trial Logistic Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Thermo Fisher Scientific Main Business Overview
11.9.5 Thermo Fisher Scientific Latest Developments
11.10 Capsugel
11.10.1 Capsugel Company Information
11.10.2 Capsugel Clinical Trial Logistic Product Offered
11.10.3 Capsugel Clinical Trial Logistic Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Capsugel Main Business Overview
11.10.5 Capsugel Latest Developments
11.11 UDG Healthcare
11.11.1 UDG Healthcare Company Information
11.11.2 UDG Healthcare Clinical Trial Logistic Product Offered
11.11.3 UDG Healthcare Clinical Trial Logistic Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 UDG Healthcare Main Business Overview
11.11.5 UDG Healthcare Latest Developments
11.12 DHL International GmbH
11.12.1 DHL International GmbH Company Information
11.12.2 DHL International GmbH Clinical Trial Logistic Product Offered
11.12.3 DHL International GmbH Clinical Trial Logistic Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 DHL International GmbH Main Business Overview
11.12.5 DHL International GmbH Latest Developments
11.13 Bilcare Limited
11.13.1 Bilcare Limited Company Information
11.13.2 Bilcare Limited Clinical Trial Logistic Product Offered
11.13.3 Bilcare Limited Clinical Trial Logistic Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Bilcare Limited Main Business Overview
11.13.5 Bilcare Limited Latest Developments
11.14 PRA Health Sciences
11.14.1 PRA Health Sciences Company Information
11.14.2 PRA Health Sciences Clinical Trial Logistic Product Offered
11.14.3 PRA Health Sciences Clinical Trial Logistic Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 PRA Health Sciences Main Business Overview
11.14.5 PRA Health Sciences Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.